The Medication(s) listed below have been approved by the Food & Drug Administration (FDA) as orphan products for treatment of this condition. There may be other products available
that are not considered orphan products.
Nitric oxide (Brand name: INOmax®)
- Manufactured by
INO Therapeutics, Inc.
FDA-approved indication: In conjunction with ventilatory support and other appropriate agents, in the treatment of term and near-term (>34 weeks) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension, where it i
National Library of Medicine Drug Information Portal